- The China State Administration for Market Regulation issued an antitrust clearance for chipmaker Analog Devices, Inc’s (NASDAQ:ADI) proposed acquisition of peer Maxim Integrated Products, Inc. (NASDAQ:MXIM).
- It is a big win amid a rigorous global regulatory environment that saw roadblocks to NVIDIA Corp’s (NASDAQ:NVDA) Arm deal.
- Analysts have also hailed the arrangement amid the intense chip crisis environment, which is likely to persist beyond 2021.
- Strong end-markets drove Analog Devices’ Q3 revenue of $1.8 billion, up 20.8% year-on-year, beating the consensus of $1.71 billion.
- Price Action: ADI shares traded higher by 1.78% at $169.60, and MXIM shares traded higher by 4.82% at $106.55 in the premarket session on the last check Monday.
Lucid Diagnostics, PAVmed Majority-Owned Subsidiary Highlight Launch Of Its EsoGuard Telemedicine Program In Partnership With Telemedicine Co. UpScriptHealth, No Terms Disclosed
Chronic heartburn patients in Phoenix, Denver, Salt Lake City, and Las Vegas can now request video telemedicine physician evaluation and referral for rapid, office-based EsoGuard testing to detect esophageal precancer
